Here are relevant reports on : oral-care-market
-
Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector, mRNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR, RSV), Route of Administration (IM, SC, Oral)-Global Forecast to 2030
The global vaccines market (excluding COVID-19 vaccines), valued at USD 49.59 billion in 2024, stood at USD 47.65 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of USD 67.91 billion by the end of the period.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), End User (Hospitals, Clinics) - Global Forecast to 2030
The global veterinary vaccines market, valued at USD10.94 billion in 2024, stood at USD11.63 billion in 2025 and is projected to advance at a resilient CAGR of 6.8% from 2025 to 2030, culminating in a forecasted valuation of USD16.15 billion by the end of the period. The continuous focus on developing novel and advanced vaccines, combined with the increasing application of these vaccines in emerging economies, is expected to drive market growth.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Excipients Market by Product ((Organic (Oleochemicals, Cellulose, Glycols), Inorganic)), Functionality (Fillers & Diluents, Binders, Lubricants), Formulation (Oral, Parenteral), Functionality Application (Stabilizers) - Global Forecast to 2030
The global pharmaceutical excipients market, valued at US$10.5 billion in 2024, stood at US$11.0 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$14.9 billion by the end of the period. Growing demand for pharmaceutical products and generic medications, along with increasing investments in research and development for innovative excipient formulations, are key drivers fueling market expansion
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Drug Delivery Market By Administration Route (Oral, Injectable, Topical, Ocular, Nasal, Transmucosal & Implantable, Pulmonary, Transdermal Patch), Application (Cancer, Diabetes, Cardiovascular), Facility of Use - Global Forecast to 2031
The global pharmaceutical drug delivery market size is expected to reach USD 2,922.82 billion by 2031 from USD 2,152.45 billion in 2026, recording a CAGR of 6.3% during the forecast period. The Key Players Johnson & Johnson Services (US), Pfizer Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Eli Lilly and Company (US), Novartis AG (Switzerland), GSK plc (UK), AbbVie Inc. (US), Sanofi (France), Merck & Co., Inc. (US), and Amgen Inc. (US). Some of the prominent players operating in the global pharmaceutical drug delivery devices market include BD (US), Cardinal Health (US), SHL Medical (Switzerland), Gerresheimer AG (Germany), and Stevanato Group (Italy).
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Veterinary Biologics Market by Product (Monoclonal Antibodies, Diagnostic Kits, Immunoglobulins & Antitoxins), RoA (Injectable, Oral), Application (Infectious Disease Prevention, Dermatology, Pain Management), Animal, End User - Global Forecast to 2030
The global veterinary biologics market, valued at US$2.61 billion in 2024, stood at US$2.72 billion in 2025 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2030, culminating in a forecasted valuation of US$3.51 billion by the end of the period. The market growth is fueled by increasing demand for effective animal therapeutics, rising populations of livestock and companion animals, and greater awareness of animal health and disease prevention.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Feed Anticoccidials Market by Livestock (Poultry, Ruminant, Swine), Type (Monensin, Salinomycin, Narasin, Diclazuril), Form (Dry, Liquid), Source (Chemical, Natural), Mode of Consumption (Oral, Injection) And Region - Global Forecast to 2025
The feed anticoccidials market is estimated to account for USD 331 million in 2019 and is projected to reach USD 429 million by 2025, at a CAGR of 4.4% during the forecast period. Elanco Animal Health (US), Huvepharma (Bulgaria), Phibro Animal Health (US), Ceva Animal Health (France), Zoetis (US), Impextraco (Belgium), Kemin Industries (US), Merck Animal Health (US), Virbac SA (France), Zydus Animal Health (India), Bioproperties Pty. Ltd. (Australia), and Qilu Animal Health Products Co. Ltd. (China).
- Published: July 2019
- Price: $ 4950
- TOC Available:
-
Asia Pacific Animal Parasiticides Market by Type [Ectoparasiticides (Pour-ons & Spot-ons, Dips), Endoparasiticides (Oral Liquids, Injectables, Feed Additives), Endectocides], Animal Type (Companion Animals, Livestock), End User - Forecast to 2031
The Asia Pacific animal parasiticides market, valued at USD 2.12 billion in 2025, stood at USD 2.26 billion in 2026 and is projected to advance at a resilient CAGR of 7.2% from 2026 to 2031, culminating in a forecasted valuation of USD 3.20 billion by the end of the period. The Asia Pacific animal parasiticides market is growing due to rising levels of parasite infestation among livestock and companion animals, expanding animal populations, and greater focus on preventive animal healthcare.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024
The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. Some of the major players in this market include Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd. (India).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Migraine Drugs Market by Product Type (Acute migraine treatment, Preventive migraine treatment), Route of administration (Oral, Injection, and Others), and End User (Hospital pharmacies, Retail pharmacies, Online pharmacies) - Global Forecast to 2023
The global Migrane Drugs market is expected to reach USD 3.96 billion by 2023 from USD 1.95 million in 2018, growing at a CAGR of 15.2%. Increasing awareness about novel therapies, launch of Calcitonin Gene-related Peptide (CGRP), increasing incidence of migraines and launch of new drugs are some of the major factors driving the growth of the global suture anchor market. These driving factors consequence to the rapid adoption of these new drugs, thus propelling the market growth.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Animal Antibiotics and Antimicrobials Market by Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide), Mode of Delivery (Premixes, Oral Solution, Injection), Animal (Food producing & Companion) & Region - Global Forecast to 2026
The global animal antibiotics market growth is primed to transition from $4.7 billion in 2021 to $5.6 billion by 2026, showcasing a strong CAGR of 3.6%. Market growth can largely be attributed to the rising demand for animal-derived food products, increasing incidence of zoonotic diseases, and the implementation of regulations to prevent the spread of animal diseases.
- Published: March 2021
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
